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Dynamic changes in DNA methylation of
stress-associated genes (OXTR, BDNF ) after acute
psychosocial stress
E Unternaehrer1,6, P Luers2,6, J Mill3, E Dempster3, AH Meyer4, S Staehli1,2, R Lieb1, DH Hellhammer2 and G Meinlschmidt1,5
Environmentally induced epigenetic alterations are related to mental health. We investigated quantitative DNA methylation status
before and after an acute psychosocial stressor in two stress-related genes: oxytocin receptor (OXTR) and brain-derived
neurotrophic factor (BDNF ). The cross sectional study took place at the Division of Theoretical and Clinical Psychobiology,
University of Trier, Germany and was conducted from February to August 2009. We included 83 participants aged 61–67 years.
Thereof, 76 participants completed the full study procedure consisting of blood sampling before (pre-stress), 10 min after
(post-stress) and 90 min after (follow-up) the Trier social stress test. We assessed quantitative DNA methylation of whole-blood
cells using Sequenom EpiTYPER. Methylation status differed between sampling times in one target sequence of OXTR
(Po0.001): methylation increased from pre- to post-stress (P¼ 0.009) and decreased from post-stress to follow-up (Po0.001).
This decrease was also found in a second target sequence of OXTR (P¼ 0.034), where it lost statistical significance when blood
cell count was statistically controlled. We did not detect any time-associated differences in methylation status of the examined
BDNF region. The results suggest a dynamic regulation of DNA methylation in OXTR—which may in part reflect changes in blood
cell composition—but not BDNF after acute psychosocial stress. This may enhance the understanding of how psychosocial
events alter DNA methylation and could provide new insights into the etiology of mental disorders.
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Introduction
DNA methylation is an epigenetic mechanism related to
mental and physical health and disease.1–4 Aberrant DNA
methylation has been implicated in the etiology of various
mental disorders including, depression,5–9 psychotic disor-
ders,10–15 post-traumatic stress disorder,16,17 autism,18,19
eating disorders20,21 and substance dependence (for review
see22), but also has an important role in the pathology of
physical illnesses, such as cancer.23 Thereby DNA methyla-
tion provides a biological basis for gene–environment
interactions relevant to mental health24: animal and human
studies have found that early life experiences can alter DNA
methylation and affect gene expression and behavior.25–32
Similarly, experiences later in life can modify the epigen-
ome.33,34 However, changes in DNA methylation immediately
after adverse experiences, such as acute psychosocial
stress, have not yet been investigated. Insight into how acute
psychosocial stress affects DNA methylation may further
elucidate our understanding of etiological mechanisms in
mental health. Therefore, we investigated DNA methylation
of two stress-related candidate genes—oxytocin receptor
(OXTR)35 and brain-derived neurotrophic factor (BDNF)35,36—
before and after an acute psychosocial stressor.
We included the OXTR because the oxytocin system
interacts with the hypothalamic-pituitary-adrenal axis35,37–40
and cardiovascular stress reactivity.41,42 To the best of our
knowledge, there have been no studies investigating methyl-
ation of OXTR with reference to stress in humans or animals.
A study on patients suffering from autism spectrum disorder
revealed aberrant DNA methylation in an OXTR region in
peripheral mononuclear blood cells; similar results were found
for brain tissue.43
BDNF, the second candidate gene, encodes a neuronal
growth factor involved in neuronal development, cell differ-
entiation and synaptic plasticity.44,45 In addition to its pivotal
role in the central nervous system, BDNF is also expressed
in the periphery where it shows neuro-protective action.46
Peripheral BDNF concentration is decreased in various
stress-related mental disorders47 including depression48 and
post-traumatic stress disorder.49 Previous work has also
shown that early life- and chronic stress resulted in a higher
methylation status of Bdnf,32 and a decrease in Bdnf mRNA
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and BDNF protein levels in several rodent brain areas.32,50–54
Animal studies have examined dynamic changes in DNA
methylation of Bdnf associated with memory, learning
and physical activity,55–57 but not following a psychosocial
stressor.
The aim of this study was to investigate dynamic changes
in DNA methylation in stress-related genes after an acute
psychosocial stressor.
Materials and methods
Participants and procedure. The sample of this cross-
sectional study consisted of 76 adults. All participants under-
went three sequential study parts:
In the first study part (2006–2007), we contacted Trier
inhabitants born between 1942 and 1947. This population
experienced war adversities early in life and was chosen as
the overall goal of the initial project was to assess long-term
consequences of early adversities. Of 2117 contacted adults,
365 completed psychological and medical questionnaires. In
the second study part (2007–2008), we invited participants
from the first study part for a psychological interview. Thereby,
exclusion criteria were medical conditions potentially interfer-
ing with planned biological measures: impaired general health
status, signs of acute infection, untreated hypertension (blood
pressure 4160/95 mm Hg during unstimulated conditions) or
diabetes mellitus, intake of glucocorticoid-, immunosuppres-
sive-, anti-depressant- or antidiabetic-medication, current
therapy for a mental disorder and previous participation in a
study applying the Trier social stress test (TSST).58,59 We
invited 274 persons, of whom 179 completed the interview.
The third study part (2009) consisted of a laboratory session
at the Division of Theoretical and Clinical Psychobiology,
University of Trier, Germany. Those participants of the second
study part who did not suffer from clinically relevant symptoms
of depression (assessed by the German Version of the Center
for Epidemiological Studies Depression Scale60) and did not
meet the above-described exclusion criteria were invited
for the third study part. Of the 127 invited participants, 83
took part in the third study part. Blood samples of seven
participants did not contain enough blood for analysis and had
to be excluded from the statistical analyses. Thus the final
sample consisted of 76 adults—43 women and 33 men—aged
between 61 and 67 years (mean age: 64.11 years; s.d.: 1.65
years). Participants gave written informed consent in accor-
dance with the Declaration of Helsinki and received financial
compensation. The Chamber of Physicians (Landesa¨rztekammer
Rheinland-Pfalz, Germany) approved the study protocol.
For the laboratory session of the third study wave, we
requested participants to abstain from heavy sports and
alcohol the evening before and on the day of testing. In
addition, they were asked to have a regular meal on the testing
day and to avoid eating and drinking 2 hours before arriving at
the laboratory. Upon arrival, we acquainted the participants
with the staff and informed them about the general proce-
dures. A study physician undertook a medical examination
and placed a peripheral venous catheter into the antecubital
vein of the nondominant arm for multiple blood draws. A study
assistant then conducted two memory tests before starting
with the TSST, which took place in a remote room, equipped
with a standing microphone and a video camera in front of two
desks. The TSST consisted of a 3-min anticipation period
and a 10-min test period, during which the participants had
to undergo a fictitious job interview and perform mental
arithmetics in front of one male and one female expert, trained
in behavioral observation techniques, as well as in abstaining
from giving any positive or negative social cues. The experts
were of about the same age as the participants themselves,
wore white doctor coats and used stop watches in order to
check time. Study participants were informed that they would
be video- and speech-taped during the whole test period for
later evaluation of his or her performance and behavior. After
the TSST, we accompanied the participants back to a study
room, where they were asked to complete two additional
memory tests and to fill in several questionnaires. The whole
study session took 3.5 h.
Blood sampling, pre-analytics and blood cell count. At
each blood sample collection, a study physician drew 5.5-ml
blood from a peripheral venous catheter (Vasofix safety,
Braun Melsungen AG, 18G, Melsungen, Germany) in EDTA-
coated S-Monovettes (Sarstedt, Nuembrecht, Germany). Blood
was taken 1 min before the TSST (pre-stress sampling), 10 min
after the TSST (post-stress sampling) and 90 min after
the TSST (follow-up sampling). To avoid acute orthostatic
influences on pre-stress blood analyses, we asked persons
to stand up and remain standing 10 min before the TSST until
we collected the pre-stress blood sample.
EDTA samples collected for later blood counts were stored
without centrifugation in a refrigerator until the end of the testing
session. We delivered these samples to an external labora-
tory (SynLab Trier, Trier, Germany) the same day. Complete
blood cell counts were obtained using an automated haematology
analyzer (Sysmex XE2100i, Norderstedt, Germany).
Immediately after collection, EDTA samples for DNA
methylation analysis were put on ice and centrifuged within
5 min (4000 rpm at þ 6 1C for 10 min) before freezing
at –80 1C. The QIAamp DNA Blood Midi (Qiagen, Hilden,
Germany) was used to extract DNA, following the manufac-
turer’s protocol. Samples were stored at  20 1C for subse-
quent DNA methylation analysis.
DNA methylation analysis. Genomic DNA (540 ng) was
treated with sodium bisulfite using the EZ-96 DNA Methyla-
tion Kit (Zymo Research, CA, USA) according to the
manufacturers’ standard protocol. Bisulfite PCR amplification
of two target sequences in OXTR (OXTR1, OXTR2) and one
target sequence in BDNF was conducted using Hot Star Taq
DNA polymerase (Qiagen). The OXTR1 target sequence is
located in the protein-coding region of OXTR exon III; the
OXTR2 target sequence partly covers the noncoding and
protein-coding promoter regions of OXTR exon III. Both
target sequences were designed to cover the OXTR
promoter region and the CpG island comprising exons
I–III.61 The BDNF target sequence around the 30 end of
BDNF exon VI is situated mainly within a CpG island that
covers BDNF exons V, Vh and VI.62 BDNF exon VI is
frequently expressed especially in non-neuronal tissue of the
periphery.62 PCR products were prepared according to the
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manufacturer’s standard protocol for quantitative DNA
methylation analysis using EpiTYPER 1.0 (Sequenom, CA,
USA). For each run, a fully methylated positive control (New
England BioLabs) and a blank control (distilled water) were
included. The assays for the amplicons were designed using
the Sequenom EpiDesigner software (for target sequences
see Supplementary information).
Statistical analysis. The resolution of EpiTYPER yielded
CpG units consisting of 1–6 individual CpG sites: 11 CpG
units for OXTR1, 28 CpG units for OXTR2 and 12 CpG units
for BDNF. Two CpG units in OXTR1, one CpG unit in OXTR2
and one CpG unit in BDNF could not be measured because
of upper and lower detection limits of Sequenom EpiTYPER.
CpG units with420% missing data were excluded, which left
eight CpGs units for OXTR1, 27 for OXTR2 and 10 for BDNF
for statistical analyses. All sample CpG methylation values
were compared with the values of the fully methylated
positive control: If the value of the sample exceeded the
value of the positive control, the value was set as missing
data. All blank controls were negative. We identified sus-
picious samples by setting outlier values as missing data
(X3 s.d.’s from mean methylation of the respective CpG
unit). By conducting missing analyses separately for each
gene, samples with 420% missing data were identified and
excluded from the statistical analyses of the respective
gene. Methylation values (OXTR2 and BDNF) were log-
transformed to meet assumptions of normality and homo-
scedasticity. We analyzed time-associated changes in mean
DNA methylation (averaged across CpG units) using multi-
level models.63 The three hierarchical levels were subjects,
CpGs within subjects, and time within CpGs within subjects.
Methylation values were allowed to vary across time for
individual CpGs within subjects as this improved model fit. In
a first step, we examined overall effects of sampling time and
analyzed differences between the three sampling time points
using post-hoc contrasts. In a second step, we tested the
same overall effect of sampling time while including blood
cell counts as covariates.64 In both models, we included
the identities of the bisulfite conversion plates and the
Sequenom plates as covariates to negate laboratory batch
effects. As we did not find any gender differences in DNA
methylation, we did not include gender as potential con-
founder in the final models. We considered an alpha level of
o0.05 as significant. All analyses were conducted using
SPSS 20. DNA methylation values are presented as percent
of cytosine methylation (%5MeC).
Results
Estimated means from the multilevel model of methylation
(%5MeC) averaged across all CpG units of a target sequence
and descriptive values of blood cell count are shown in
Table 1.
Methylation of OXTR1. We found an overall effect for
sampling time on OXTR1 mean methylation status. All post-
hoc contrasts between sampling times were significant, with
the greatest difference in mean methylation between post-
stress and follow-up (Figure 1a, Table 2). Moreover, seven
of eight individual CpG units within OXTR1 revealed
significant time effects (Figure 1b). Notably, when adjusting
for blood cell counts, the overall effect of sampling time on
OXTR1 methylation averaged across CpG units remained
significant. However, of the three post-hoc contrasts, the
one between pre-stress and post-stress was no longer
significant.
Methylation of OXTR2. We found a trend effect for sampling
time in OXTR2. Post-hoc contrast analyses indicated a
difference in OXTR2 mean methylation between post-stress
and follow-up (Figure 2a, Table 2). Time effects were signi-
ficant in two of 27 CpG units (Figure 2b). After adjustment for
blood cell count, the overall effect for sampling time remained
nonsignificant; the contrast between post-stress and follow-up
was no longer significant.
Methylation of BDNF (Figure 3, Table 2). The analysis
revealed no overall effect for sampling time on BDNF
mean methylation and no post-hoc contrast was significant
Table 1 Estimated means and 95% confidence intervals (CI) from the multilevel model of methylation (%5MeC) averaged across CpG units of each target sequence
and descriptive values of blood cell count for each sampling time (pre-stress, post-stress and follow-up)
Sampling time
Pre-stress Post-stress Follow-up
M 95% CI M 95% CI M 95% CI
Methylation (%5MeC)
OXTR1 17.64 16.4818.81 18.02 16.85 19.19 16.98 15.79 18.16
OXTR2
a 5 4.675.35 5.06 4.73 5.42 4.76 4.42 5.11
BDNF a 6.61 6.107.15 6.56 6.05 7.10 6.31 5.80 6.84
Blood cell count
Leukocytesb 6.53 6.256.80 7.01 6.69 7.32 6.74 6.41 7.06
Lymphocytesc 30.59 28.9832.21 32.61 30.85 34.36 26.74 25.09 28.40
Monocytesc 8 7.578.43 8.24 7.75 8.74 7.54 7.06 8.01
Granulocytesc 62.12 60.6363.60 59.60 58.05 61.16 65.45 63.55 67.34
Abbreviations: BDNF, brain-derived neurotrophic factor; 95% CI, 95% confidence interval; M, mean; OXTR, oxytocin receptor.
aEstimates were re-transformed from natural logarithm to %5MeC; bNumber103/ml; c% of leukocytes.
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(Figure 3a, Table 2). However, analysis of individual CpG
units revealed a significant time effect in 1 of 10 CpG units
(Figure 3b). The inclusion of blood cell count as covariates
did not change these results.
Discussion
The aim of this study was to investigate immediate changes
in DNA methylation in stress-related genes after acute
Figure 1 (a) Estimated mean DNA methylation level (%5MeC) in OXTR1
amplicons averaged across CpGs at pre-stress, post-stress, and 90 min follow-up
stress assessments. Error bars are s.e. of the estimated mean. (b) Differences in
individual CpG mean methylation (%5MeC) from pre-stress to post-stress and from
pre-stress to follow-up. All estimates obtained from the unadjusted model. *Po0.05.
Table 2 Overall effects of sampling time on mean methylation ofOXTR1,OXTR2
a andBDNF a without and with adjustment for blood cell count as covariates; post-hoc
contrasts between sampling times pre-stress, post-stress and follow-up. Results based on multilevel analysis
Main effects Contrasts Number of observations
df b F p C1 C2 C3 N
p p p
OXTR1
Overall model 2; 802 25.84 o0.001 0.009 o0.001 o0.001 600
Adjusted for blood cell count 2; 1133 10.70 o0.001 0.278 o0.001 o0.001 600
OXTR2
a
Overall model 2; 2998 2.46 0.086 0.672 0.034 0.099 2045
Adjusted for blood cell count 2; 1368 1.92 0.146 0.536 0.058 0.137 2044
BDNF a
Overall model 2; 1098 1.31 0.271 0.780 0.184 0.139 747
Adjusted for blood cell count 2; 1523 0.87 0.418 0.536 0.518 0.191 737
Abbreviations: BDNF, brain-derived neurotrophic factor; C1, contrast pre-stress versus post-stress; C2, contrast post-stress versus 90 min after stress; C3, contrast
pre-stress versus 90 min after stress; OXTR, oxytocin receptor.
aNatural logarithm transformed; bNumerator; denominator.
Figure 2 (a) Estimated mean DNA methylation level (%5MeC) in OXTR2
amplicons averaged across CpGs at pre-stress, post-stress and 90 min follow-up
stress assessments. Error bars are s.e. of the estimated mean. (b) Differences in
individual CpG mean methylation (%5MeC) from pre-stress to post-stress and from
pre-stress to follow-up. All estimates obtained from the unadjusted model. *Po0.05.
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psychosocial stress. We found stress-associated DNA methy-
lation changes in one of two OXTR target sequences but not
in the assessed target sequence of BDNF, suggesting a
considerable variation in the sensitivity of short-term DNA
methylation responses among different stress-related genes.
For OXTR1, we found an increase in DNA methylation from
pre-stress to post-stress and a decrease from post-stress to
follow-up. In OXTR2, methylation decreased from post-stress
to follow-up only. Notably, in OXTR1 the time-associated
changes, as well as the difference from post-stress to follow-
up, remained significant even after controlling for blood
cell count. The changes from pre-stress to post-stress in
OXTR1 and from post-stress to follow-up in OXTR2 may have
been secondary to stress-associated changes in blood cell
composition.65
Although (i) methylation increase in OXTR is associated
with decreased OXTR expression61 and (ii) the oxytocin
system antagonizes the short-term stress response,37,41
methylation increase from pre- to post-stress in OXTR1 could
constitute a part of the immediate stress response, which
relies on rapid autonomic sympathetic activation to mobilize
resources and increase performance.66 After the stressor had
passed, DNA methylation of the OXTR not only receded back
to pre-stress baseline, but also fell below pre-stress levels.
This could indicate an overcompensating mechanism in
OXTR methylation after acute psychosocial stress, allowing
for an upregulation of the oxytocin system as a middle-term
physiological buffer of the acute stress response. Previous
studies have shown that the oxytocin system has an essential
role in the regulation of blood pressure and volume, heart rate
and cardiovascular homeostasis, as well as in the cardiovas-
cular response to stress.42,67,68 Therefore, a decrease in
DNA methylation of the OXTR and the subsequent increase
in expression43 may indeed be a potential mechanism to
support physiological recovery after acute stress on an
epigenetic level.
Regarding BDNF, our results suggest that in the periphery,
DNA methylation in BDNF remains stable after a short and
non-recurring psychosocial stressor. Previous studies found
lifelong and transgenerational perpetuation of changes in
BDNF methylation after early-life adversity.32 Fuchikami
et al.69 recently suggested DNA methylation of BDNF in
peripheral blood as a diagnostic biomarker of major depres-
sion. These results and our finding implicate that BDNF
methylation has a long-term, rather than a short-term, role in
stress adaptation.
This study has several strengths: First, the TSST is a highly
established and robust standardized protocol to induce
psychosocial stress and a robust hypothalamic-pituitary-
adrenal axis activation.70 Various biological markers of acute
stress have been investigated in relation to the TSST. Here we
extend previous findings, by adding DNA methylation
changes in OXTR as an additional biomarker of acute
psychosocial stress, especially from post-stress to 90 min
after the stressor. Second, we included blood cell count as a
time-varying covariate into the analyses to ensure that DNA
methylation changes were not the result of alterations in blood
cell composition in response to stress.64 Indeed, our results
highlight the necessity to consider blood cell count in the
analyses while investigating DNA methylation in the periph-
ery. Third, DNA methylation was not only assessed at pre-
and post-stress, but also after a time interval of 90 min,
which provided insight into methylation changes after stress
recovery. Fourth, the focus on not only one, but on multiple
genes (OXTR and BDNF) and target sequences revealed
remarkable specificity of the short-term DNA methylation
response of individual stress-related genes.
Several limitations of this study should also be noted: First,
we measured DNA methylation in peripheral blood, which
does not allow us to directly draw conclusions about proces-
ses in the central nervous system. To what degree DNA
methylation in the periphery corresponds to DNA methylation
in the brain remains to be elucidated, although some studies
suggest certain consistency across tissues.43,71,72 Second,
we did not apply an unstressed control group and can
therefore not completely exclude that DNA methylation
changes were due to factors unrelated to the psychosocial
stress experience. Third, we analyzed DNA methylation
changes after acute psychosocial stress in a study population
with high likelihood of early experiences of war-related
adversities, who may have been sensitized to stress. As a
consequence, study subjects might have been especially
susceptible to changes in OXTR DNA methylation after acute
psychosocial stress. Therefore, generalizability of our results
to populations without early adversities may be limited.
Figure 3 (a) Estimated mean DNA methylation level (%5MeC) in BDNF
amplicons averaged across CpGs at pre-stress, post-stress and 90 min follow-up
stress assessments. Error bars are s.e. of the estimated mean. (b) Differences
in individual CpG mean methylation (%5MeC) from pre-stress to post-stress and
from pre-stress to follow-up. All estimates obtained from the unadjusted model.
*Po0.05.
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Fourth, it should be noted that differences in mean DNA
methylation between time points were small, and the
functional effects of such modest alterations are not known.
In this context, however, the following should be considered:
(i) We did not compare different study groups, but assessed
changes in DNA methylation over time within the same indivi-
duals. Therefore mean values in methylation are not indepen-
dent of each other and differences are expected to be smaller
in contrast to between-group comparison. (ii) Changes in
DNA methylation were larger for several individual CpG units
than for averaged target sequences (Figures 1–3). (iii) The
absolute change of 1% in methylation of OXTR1 (%5MeC)
from post-stress to follow-up represents a relative change
of 5–6%. (iv) DNA methylation changes may accumulate and
increase in magnitude in case of repeated psychosocial stress
experience.
Future studies should replicate our findings for OXTR and
BDNF, but also include additional stress-related candidate
genes. Furthermore, we suggest shortening blood-sampling
intervals to identify the time point of greatest DNA methylation
changes. In addition, future studies could assess DNA methy-
lation not only after different stressors, but also after positive
experiences to determine whether DNA methylation is
sensitive not only to aversive but also to positive psychosocial
experiences. Moreover, subjects from other populations (such
as cohorts without increased likelihood of early adversities)
should be studied to scrutinize the generalizability of our
results. Finally, future studies should assess DNA methylation
after repeated psychosocial experiences to elucidate possible
long-term modifications in DNA methylation. Identifying
and studying short- and long-term effects of psychosocial
experiences—which for example could reverse aberrant DNA
methylation—could become an important goal in the devel-
opment of new treatment approaches.
Conclusion
To the best of our knowledge, this is the first study in humans
investigating dynamic short-term changes in DNA methylation
related to a specific life event, namely a psychosocial stressor.
We found different DNA methylation states in the OXTR when
comparing pre-stress, post-stress and 90-min follow-up
stress measurement. These findings contribute to the under-
standing of epigenetic mechanisms in general, but may
also have clinical significance in the future: We found that
psychosocial experiences are linked to immediate epigenetic
modifications in a sample of subjects with early adverse
experiences. This could have clinical implications regarding
the etiology of mental and stress-related disorders, as well as
of general medical conditions.
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